4.7 (302) · € 25.50 · En Stock
The global market for acute and preventive anti-migraine drugs estimated reach $15.6 billion by 2029, expanding at a CAGR of 9.9% over the forecast period, driven by enormous patient population, high cost of innovative new drugs, and strong pipeline of novel therapies.
Migraine Drugs Market Size Global Report, 2022 - 2030
Global Preventive Healthcare Market $415 Billion by 2031
interest rates - definition. Financial dictionary
EX-13
Migraine market continues exponential growth - IQVIA
Global Migraine Drugs Market Report 2030: A $2.2 Billion Market by
10-K
Anti-hypertensive Drugs Market Size & Share Report 2030
Frontiers The ATP sensitive potassium channel (KATP) is a novel